External Evaluation
Evaluation by Outside Organizations
External awards
ZAK Award given by AACC for development of sd LDL-C test reagent (August 5, 2019, Anaheim, US)
Yasuki Ito,General manager of Diagnostic Reagents Academic Research Department at Denka Seiken Co., Ltd., which is a consolidated subsidiary of Denka Company Limited, has received the ZAK Award from the American Association for Clinical Chemistry (AACC) for services in developing “small, dense LDL-C,*1” a diagnostic reagent used in automated chemistry analyzers.*2
The ZAK Award was established by the AACC in 1990 in honor of Dr. Bennie Zak who rendered distinguished services in the field of clinical testing. It is an honorable award bestowed once every two years by the AACC Lipoproteins and Vascular Diseases Division (LVDD) to persons who have made remarkable contributions to clinical chemistry research in the same field.
The award ceremony took place on August 5, 2019 at an AACC LVDD seminar being held in Anaheim in the US. The recipient, Yasuki Ito, presented a commemorative speech after receiving the award from Katsuyuki Nakajima, chairman of the LVDD.
Denka Seiken has been selling the sd LDL-C diagnostic reagent based on this development in the US since July 2018 as an in-vitro diagnostic (IVD) reagent.*3 Being a product that can evaluate the risk of heart disease simply, quickly and cost-effectively, Denka Seiken is stepping up business expansion in Japan and China, as well as in the US, and will continue to contribute to the maintenance of human health and the prevention of disease.
Award ceremony at the AACC LVDD seminar on August 5, 2019 (Anaheim, US)
Yasuki Ito, general manager of the Diagnostic Reagent Science Department, Denka Seiken Co., Ltd. (left)
Katsuyuki Nakajima, chairman of the LVDD, American Association for Clinical Chemistry (AACC) (right)
- *1sd LDL-C (small, dense LDL cholesterol): marker for evaluating the risk of cardiovascular diseases
- *2AACC website: Lipoproteins and Vascular Diseases Division Awards
https://www.aacc.org/community/divisions/lipoproteins-and-vascular-diseases/awards - *3News release (July 31, 2018): The Denka Group Begins U.S. Sales of In-Vitro Diagnostic Reagent for Heart Disease Risk Marker sd LDL-C
https://www.denka.co.jp/eng/storage/news/pdf/204/20180731_sd%20LDL-C_en.pdf
Denka receives an B rating in “Climate Change” and a A rating in “Water Security” from CDP 2024
Denka announces that it was awarded an B rating in Climate Change, an...
Economy, Trade and Industry Minister’s Award received at Industrial Standardization Awards for achievements in international standardization activities (October 8, 2019)
At a ceremony for the METI Industrial Standardization Awards held on Octo...
Global uruoi website receives “awwwards. Site of the Day” (August 23, 2019)
The global uruoi website, which is administered by Denka Corporation (New...
ZAK Award given by AACC for development of sd LDL-C test reagent (August 5, 2019, Anaheim, US)
Yasuki Ito,General manager of Diagnostic Reagents Academic Research Depar...
Outstanding Research Award received from Society for Chemistry and Micro-Nano Systems (May 27, 2019)
At the 39th Conference of the Society for Chemistry and Micro-Nano System...
Paper written by Denka researchers selected for cover of UK journal Analyst (March 7, 2019)
A paper written by Denka researchers, including Shuhei Aoyam...